Last edition
News about
BDMA to set up tech, training centre in Hyderabad
The technology centre will act as a centralised location for high-end research and testing and will strengthen the role of the pharma cluster
Mumbai Vaishali Pharma bags Rs 600 Cr order for antibiotics pharma products
Vaishali Pharma holds altogether 250+ brands in finished formulations
Zydus receives US FDA approval for Olmesartan Medoxomil and Hydrochlorothiazide tabs
The company also receives approval for Apixaban Tablets, 2.5 mg and 5 mg
Corning Incorporated, SGD Pharma to set up pharma packaging facility in Telangana
US-headquartered Foxx Life Sciences will be investing Rs 200 crore to expand capabilities in pharmaceutical SUT
<br />
Veranova finishes mid-scale API expansion at Edinburgh facility
The multi-purpose asset, able to handle highly active APIs and intermediates, is positioned to enable growth in the generic opioid analgesic and anti-addiction markets
Puritas Asgard completes API facility cleanroom expansion
The facility will manufacture APIs critical for critical medications and life-saving drugs
Jubilant Bhartia Group to set up facility in the Genome Valley, Hyderabad
The announcement was made during BioAsia 2023
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products
Granules India receives ANDA Approval for Losartan Potassium tabs
Granules now have a total of 54 ANDA approvals from the US FDA
<br />
Strides flagship facility in Bengaluru receives US FDA inspection closure
The company's flagship facility was inspected by the US FDA between December 5 and 9, 2022, and a form 483 listing three inspectional observations was issued
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy